Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Association Between ABCA1 R219K Variant and Alzheimer's Disease: An Updated Meta-Analysis and Systematic Review

Author(s): Jinrong Zhao*, Jinpei Wang*, Dong Zhao, Lin Wang* and Xiaoe Luo

Volume 19, Issue 10, 2022

Published on: 05 December, 2022

Page: [734 - 741] Pages: 8

DOI: 10.2174/1567205020666221114112838

Price: $65

Abstract

Background: Over a dozen studies have investigated the effect of the R219K variant in the ATP-binding cassette transporter A1 (ABCA1) gene on the risk of Alzheimer's disease (AD), but the results are conflicting.

Objective: We performed a systematic review and meta-analysis to comprehensively assess the association between the ABCA1 R219K variant and the risk of AD.

Methods: Studies included in the meta-analysis were obtained by searching PubMed, Web of Science and AlzGene. Review Manager 5.4 was used for meta-analysis. Both the odds ratio (OR) and its 95% confidence interval (CI) were used to evaluate the effect of ABCA1 R219K polymorphism on AD susceptibility. Heterogeneity between the included studies was assessed using I2 statistics and Cochran Qtest. Funnel plots were used to assess publication bias.

Results: A total of 14 eligible studies involving 10084 subjects were retrieved from PubMed, Web of Science and AlzGene. Meta-analysis results showed that R219K polymorphism was significantly associated with a decreased risk of AD in Chinese under a recessive model (OR = 0.67; 95% CI = 0.51- 0.88; P = 0.004).

Conclusion: The present meta-analysis indicated that the KK genotype of R219K polymorphism may act as a protective factor for AD in the Chinese population. Additional studies with larger sample sizes are needed to further confirm this association.

« Previous
[1]
Ringman JM, Goate A, Masters CL, et al. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr Neurol Neurosci Rep 2014; 14(11): 499.
[http://dx.doi.org/10.1007/s11910-014-0499-8] [PMID: 25217249]
[2]
Yu JT, Xu W, Tan CC, et al. Evidence-based prevention of Alzheimer’s disease: Systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry 2020; 91(11): 1201-9.
[http://dx.doi.org/10.1136/jnnp-2019-321913] [PMID: 32690803]
[3]
Meng XF, Yu JT, Wang HF, et al. Midlife vascular risk factors and the risk of Alzheimer’s disease: A systematic review and meta-analysis. J Alzheimers Dis 2014; 42(4): 1295-310.
[http://dx.doi.org/10.3233/JAD-140954] [PMID: 25024338]
[4]
Liu Q, An Y, Ma W, et al. High cholesterol diet results in elevated amyloid β and oxysterols in rats. Mol Med Rep 2018; 17(1): 1235-40.
[http://dx.doi.org/10.3892/mmr.2017.8003] [PMID: 29115521]
[5]
Sparks DL, Scheff SW, Hunsaker JC III, Liu H, Landers T, Gross DR. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994; 126(1): 88-94.
[http://dx.doi.org/10.1006/exnr.1994.1044] [PMID: 8157129]
[6]
Xu C, Apostolova LG, Oblak AL, Gao S. Association of hypercholesterolemia with Alzheimer’s disease pathology and cerebral amyloid angiopathy. J Alzheimers Dis 2020; 73(4): 1305-11.
[http://dx.doi.org/10.3233/JAD-191023] [PMID: 31929164]
[7]
Chen L, Zhao ZW, Zeng PH, Zhou YJ, Yin WJ. Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell Cycle 2022; 21(11): 1121-39.
[http://dx.doi.org/10.1080/15384101.2022.2042777] [PMID: 35192423]
[8]
Graffelman J. Exploring diallelic genetic markers: The Hardy Weinberg package. J Stat Softw 2015; 64(3): 1-23.
[http://dx.doi.org/10.18637/jss.v064.i03]
[9]
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Available from: http://www.ohri.ca//programs/clinical_epidemiology/oxford.asp
[10]
Lupton MK, Proitsi P, Lin K, et al. The role of ABCA1 gene sequence variants on risk of Alzheimer’s disease. J Alzheimers Dis 2014; 38(4): 897-906.
[http://dx.doi.org/10.3233/JAD-131121] [PMID: 24081377]
[11]
Shibata N, Kawarai T, Lee JH, et al. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer’s disease. Neurosci Lett 2006; 391(3): 142-6.
[http://dx.doi.org/10.1016/j.neulet.2005.08.048] [PMID: 16157450]
[12]
Cascorbi I, Flüh C, Remmler C, et al. Association of ATP-binding cassette transporter variants with the risk of Alzheimer’s disease. Pharmacogenomics 2013; 14(5): 485-94.
[http://dx.doi.org/10.2217/pgs.13.18] [PMID: 23556446]
[13]
Chu LW, Li Y, Li Z, et al. A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer’s disease in Chinese. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(8): 1007-13.
[http://dx.doi.org/10.1002/ajmg.b.30525] [PMID: 17510949]
[14]
Fehér Á, Giricz Z, Juhász A, Pákáski M, Janka Z, Kálmán J. ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer’s disease. Neurosci Lett 2018; 664: 79-83.
[http://dx.doi.org/10.1016/j.neulet.2017.11.027] [PMID: 29133174]
[15]
Katzov H, Chalmers K, Palmgren J, et al. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β-amyloid metabolism. Hum Mutat 2004; 23(4): 358-67.
[http://dx.doi.org/10.1002/humu.20012] [PMID: 15024730]
[16]
Khorram Khorshid HR, Gozalpour E, Kamali K, Ohadi M, Karimloo M, Shahhosseiny MH. The association between sporadic Alzheimer’s disease and the human ABCA1 and APOE gene polymorphisms in Iranian population. Iran Red Crescent Med J 2011; 13(4): 256-62.
[PMID: 22737475]
[17]
Kölsch H, Lütjohann D, Jessen F, et al. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer’s disease. Int J Mol Med 2006; 17(5): 791-4.
[http://dx.doi.org/10.3892/ijmm.17.5.791] [PMID: 16596262]
[18]
Rodríguez-Rodríguez E, Mateo I, Llorca J, et al. Association of genetic variants of ABCA1 with Alzheimer’s disease risk. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(7): 964-8.
[http://dx.doi.org/10.1002/ajmg.b.30552] [PMID: 17510946]
[19]
Sun YM, Li HL, Guo QH, et al. The polymorphism of the ATP-binding cassette transporter 1 gene modulates Alzheimer disease risk in Chinese Han ethnic population. Am J Geriatr Psychiatry 2012; 20(7): 603-11.
[http://dx.doi.org/10.1097/JGP.0b013e3182423b6a] [PMID: 22377775]
[20]
Sundar PD, Feingold E, Minster RL, DeKosky ST, Kamboh MI. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer’s disease. Neurobiol Aging 2007; 28(6): 856-62.
[http://dx.doi.org/10.1016/j.neurobiolaging.2006.04.005] [PMID: 16725228]
[21]
Wahrle SE, Shah AR, Fagan AM, et al. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol Neurodegener 2007; 2(1): 7.
[http://dx.doi.org/10.1186/1750-1326-2-7] [PMID: 17430597]
[22]
Wang F, Jia J. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer’s disease in Chinese. Brain Res 2007; 1147: 34-8.
[http://dx.doi.org/10.1016/j.brainres.2007.02.005] [PMID: 17335784]
[23]
Wollmer M, Streffer JR, Lütjohann D, et al. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer’s disease. Neurobiol Aging 2003; 24(3): 421-6.
[http://dx.doi.org/10.1016/S0197-4580(02)00094-5] [PMID: 12600718]
[24]
Xiao Z, Wang J, Chen W, Wang P, Zeng H, Chen W. Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer’s disease. Lipids Health Dis 2012; 11(1): 163.
[http://dx.doi.org/10.1186/1476-511X-11-163] [PMID: 23181436]
[25]
Ya L, Lu Z. Differences in ABCA1 R219K polymorphisms and serum indexes in Alzheimer and Parkinson diseases in Northern China. Med Sci Monit 2017; 23: 4591-600.
[http://dx.doi.org/10.12659/MSM.903636] [PMID: 28943632]
[26]
Jiang M, Lv L, Wang H, et al. Meta-analysis on association between the ATP-binding cassette transporter A1 gene (ABCA1) and Alzheimer’s disease. Gene 2012; 510(2): 147-53.
[http://dx.doi.org/10.1016/j.gene.2012.09.009] [PMID: 22982414]
[27]
Wang XF, Cao YW, Feng ZZ, et al. Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer’s disease. Mol Biol Rep 2013; 40(2): 779-85.
[http://dx.doi.org/10.1007/s11033-012-2115-9] [PMID: 23111454]
[28]
Yin YW, Li JC, Gao D, et al. Influence of ATP-binding cassette transporter 1 R219K and M883I polymorphisms on development of atherosclerosis: A meta-analysis of 58 studies. PLoS One 2014; 9(1): e86480.
[http://dx.doi.org/10.1371/journal.pone.0086480] [PMID: 24466114]
[29]
Fan Q, Zhu Y, Zhao F. Association of rs2230806 in ABCA1 with coronary artery disease: An updated meta-analysis based on 43 research studies. Medicine 2020; 99(4): e18662.
[http://dx.doi.org/10.1097/MD.0000000000018662] [PMID: 31977856]
[30]
Jung D, Cao S, Liu M, Park S. A meta-analysis of the associations between the ATP-binding cassette transporter ABCA1 R219K (rs2230806) polymorphism and the risk of type 2 diabetes in Asians. Horm Metab Res 2018; 50(4): 308-16.
[http://dx.doi.org/10.1055/a-0583-0201] [PMID: 29621814]
[31]
Au A, Griffiths LR, Irene L, Kooi CW, Wei LK. The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis. Atherosclerosis 2017; 265: 60-70.
[http://dx.doi.org/10.1016/j.atherosclerosis.2017.08.003] [PMID: 28865324]
[32]
Mokuno J, Hishida A, Morita E, et al. ATP-binding cassette transporter A1 (ABCA1) R219K (G1051A, rs2230806) polymorphism and serum high-density lipoprotein cholesterol levels in a large Japanese population: Cross-sectional data from the Daiko Study. Endocr J 2015; 62(6): 543-9.
[http://dx.doi.org/10.1507/endocrj.EJ14-0577] [PMID: 25877294]
[33]
Shi Z, Tian Y, Zhao Z, et al. Association between the ABCA1 (R219K) polymorphism and lipid profiles: A meta-analysis. Sci Rep 2021; 11(1): 21718.
[http://dx.doi.org/10.1038/s41598-021-00961-9] [PMID: 34741058]
[34]
Li Y, Tacey K, Doil L, et al. Association of ABCA1 with late-onset Alzheimer’s disease is not observed in a case-control study. Neurosci Lett 2004; 366(3): 268-71.
[http://dx.doi.org/10.1016/j.neulet.2004.05.047] [PMID: 15288432]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy